Goodyear L J, Hirshman M F, Napoli R, Calles J, Markuns J F, Ljungqvist O, Horton E S
Research Division, Joslin Diabetes Center, Boston, Massachusetts 02215, USA.
Diabetes. 1996 Aug;45(8):1051-6. doi: 10.2337/diab.45.8.1051.
In humans, ingestion of carbohydrates causes an increase in blood glucose concentration, pancreatic insulin release, and increased glucose disposal into skeletal muscle. The underlying molecular mechanism for the increase in glucose disposal in human skeletal muscle after carbohydrate ingestion is not known. We determined whether glucose ingestion increases glucose uptake in human skeletal muscle by increasing the number of glucose transporter proteins at the cell surface and/or by increasing the activity of the glucose transporter proteins in the plasma membrane. Under local anesthesia, approximately 1 g of vastus lateralis muscle was obtained from six healthy subjects before and 60 min after ingestion of a 75-g glucose load. Plasma membranes were isolated from the skeletal muscle and used to measure GLUT4 and GLUT1 content and glucose transport in plasma membrane vesicles. Glucose ingestion increased the plasma membrane content of GLUT4 per gram muscle (3,524 +/- 729 vs. 4,473 +/- 952 arbitrary units for basal and 60 min, respectively; P < 0.005). Transporter-mediated glucose transport into plasma membrane vesicles was also significantly increased (130 +/- 11 vs. 224 +/- 38 pmol.mg-1.s-1; P < 0.017), whereas the calculated ratio of glucose transport to GLUT4, an indication of transporter functional activity, was not significantly increased 60 min after glucose ingestion (2.3 +/- 0.4 vs. 3.0 +/- 0.5 pmol.GLUT4 arbitrary units-1.s-1; P < 0.17). These results demonstrate that oral ingestion of glucose increases the rate of glucose transport across the plasma membrane and causes GLUT4 translocation in human skeletal muscle. These findings suggest that under physiological conditions the translocation of GLUT4 is an important mechanism for the stimulation of glucose uptake in human skeletal muscle.
在人类中,摄入碳水化合物会导致血糖浓度升高、胰腺胰岛素释放以及骨骼肌中葡萄糖处置增加。碳水化合物摄入后人类骨骼肌中葡萄糖处置增加的潜在分子机制尚不清楚。我们确定摄入葡萄糖是否通过增加细胞表面葡萄糖转运蛋白的数量和/或增加质膜中葡萄糖转运蛋白的活性来增加人类骨骼肌中的葡萄糖摄取。在局部麻醉下,从六名健康受试者摄入75克葡萄糖负荷前和60分钟后获取约1克股外侧肌。从骨骼肌中分离出质膜,并用于测量质膜囊泡中的GLUT4和GLUT1含量以及葡萄糖转运。摄入葡萄糖增加了每克肌肉中GLUT4的质膜含量(基础值和60分钟时分别为3524±729和4473±952任意单位;P<0.005)。转运体介导的葡萄糖转运到质膜囊泡中也显著增加(130±11对224±38 pmol·mg-1·s-1;P<0.017),而葡萄糖转运与GLUT4的计算比值(转运体功能活性的指标)在摄入葡萄糖60分钟后没有显著增加(2.3±0.4对3.0±0.5 pmol·GLUT4任意单位-1·s-1;P<0.17)。这些结果表明,口服葡萄糖可增加葡萄糖跨质膜转运的速率,并导致人类骨骼肌中GLUT4易位。这些发现表明,在生理条件下,GLUT4的易位是刺激人类骨骼肌中葡萄糖摄取的重要机制。